Abn Amro Investment Solutions Trans Medics Group, Inc. Transaction History

Abn Amro Investment Solutions

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Sep 04, 2025	BUY	$59.28 - $144.9 $74,811 - $182,863	1,262 Added 6.83%	19,732 $1.23 Billion
Q3 2024 Sep 04, 2025	BUY	$135.68 - $176.11 $2.51 Million - $3.25 Million	18,470 New	18,470 $2.9 Billion
Q2 2024 Sep 04, 2025	BUY	$72.62 - $150.62 $1.5 Million - $3.12 Million	20,688 New	20,688 $3.12 Billion
Q4 2023 Sep 05, 2025	SELL	$36.74 - $81.08 $15,834 - $34,945	-431 Reduced 2.02%	20,919 $1.65 Billion
Q3 2023 Nov 07, 2025	BUY	$53.47 - $96.07 $1.14 Million - $2.05 Million	21,350 New	21,350 $1.17 Billion

Q3 2023 Sep 05, 2025	BUY	$53.47 - $96.07 $684,469 - $1.23 Million	12,801 Added 149.74%	21,350 $1.17 Billion
Q2 2023 Sep 05, 2025	BUY	$66.23 - $88.73 $198,425 - $265,835	2,996 Added 53.95%	8,549 $718 Million
Q1 2023 Sep 05, 2025	BUY	$53.63 - $82.33 $297,807 - $457,178	5,553 New	5,553 $421 Million

443

30.4M

1.01M

928K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $3.66B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.